Traumatic Brain Injury Biomarkers, Simulations and Kinetics

Area of Science:

• Biomarkers and diagnostics
• Neuroscience
• Computational biology

Background:

• Traumatic brain injury (TBI) diagnosis relies on understanding blood-based biomarkers.
• Biomarkers for mild, moderate, and severe TBI, PTSD, and CTE require further investigation.
• The blood-brain barrier's role and biomarker kinetics post-injury are not fully understood.

Purpose of the Study:

• To review the predictive capabilities of blood-based biomarkers for TBI.
• To understand protein biomarker structure and physical properties for effective TBI prediction.
• To investigate the relationship between biomarker structure, stability, and diagnostic potential.

Main Methods:

• Molecular dynamics simulations using NAMD and VMD to analyze 12 biomarkers.
• Assessment of atomic movement, hydrogen bond energies, and thermodynamic stability.
• Review of existing literature on biomarker kinetics and clinical relevance.

Main Results:

• Identified a lower bound for protein self-dissolution based on hydrogen bonds and energy.
• Hypothesized that biomarkers with higher bonding energy and more bonds may disrupt the blood-brain barrier and remain detectable.
• Analyzed five clinically relevant biomarkers: S100B, GFAP, UCHL1, NF-L, and tau.

Conclusions:

• Biomarker structure and stability are critical for TBI diagnosis.
• Further research into biomarker kinetics and blood-brain barrier interaction is needed.
• This study provides a foundation for discovering new, reliable TBI biomarkers.